Ambu A/S (CPH:AMBU.B)
87.75
-0.10 (-0.11%)
At close: Dec 23, 2025
Ambu A/S Market Cap
Ambu A/S has a market cap or net worth of 23.39 billion as of December 26, 2025. Its market cap has decreased by -21.22% in one year.
Market Cap
23.39B
Enterprise Value
23.07B
Revenue
6.04B
Ranking
n/a
PE Ratio
38.49
Stock Price
87.75
Market Cap Chart
Since August 8, 1994, Ambu A/S's market cap has increased from 290.04M to 23.39B, an increase of 7,964.53%. That is a compound annual growth rate of 15.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 23.39B | -15.57% |
| Dec 30, 2024 | 27.70B | -1.11% |
| Dec 29, 2023 | 28.01B | 23.89% |
| Dec 30, 2022 | 22.61B | -48.49% |
| Dec 30, 2021 | 43.90B | -32.73% |
| Dec 30, 2020 | 65.26B | 138.06% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.47T |
| Genmab | 130.78B |
| Coloplast | 122.33B |
| ALK-Abelló | 50.34B |
| Demant | 45.59B |
| H. Lundbeck | 41.13B |
| Zealand Pharma | 33.95B |
| GN Store Nord | 15.18B |